Estimation of Parkinson's disease survival in Israeli men and women, using health maintenance organization pharmacy data in a unique approach

Journal of Neurology

Volumn 260, Issue 1, 2013, Pages 62-70

  Chillag Talmor, O ^a   Giladi, N ^b,c   Linn, S ^a,d   Gurevich, T ^b,c   El Ad, B ^d   Silverman, B ^d   Friedman, N ^d   Peretz, C ^c  

^a UNIVERSITY OF HAIFA   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d MACCABI HEALTHCARE SERVICES   (Israel)

Author keywords

Cohort studies; Incidence studies; Parkinson's disease; Prognosis

Indexed keywords

ANTIPARKINSON AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; GROUPS BY AGE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; ISRAEL; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARKINSON DISEASE; PHARMACY; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMMUNITY HEALTH PLANNING; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; ISRAEL; MALE; MIDDLE AGED; PARKINSON DISEASE; PHARMACY; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; SEX CHARACTERISTICS; SURVIVAL ANALYSIS; SURVIVAL RATE; YOUNG ADULT;

EID: 84872281902     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6584-5     Document Type: Article

References (11)

1. Ishihara LS, Cheesbrough A, Brayne C, Schrag A (2007) Estimated life expectancy of Parkinson's patients compared with the UK population. J Neurol Neurosurg Psychiatry 78:1304-1309
2. Brandt-Christensen M, Kvist K, Nilsson FM, Andersen PK, Kessing LV (2006) Use of antiparkinsonian drugs in Denmark: results from a nationwide pharmacoepidemiological study. Mov Disord 21:1221-1225
3. Chillag-Talmor O, Giladi N, Linn S et al (2011) Use of a refined drug tracer algorithm to estimate prevalence and incidence of Parkinson's disease in a large Israeli population. J Parkinson's Dis 1:35-47
4. Israel Central Bureau of Statistics (2010). Complete life tables of Israel, 2004-2008. Jerusalem
5. Taeger D, Sun Y, Keil U, Straif K (2000) A stand-alone windows applications for computing exact person-years, standardized mortality ratios and confidence intervals in epidemiological studies. Epidemiology 11:607-608
6. Elbaz A, Bower JH, Peterson BJ et al (2003) Survival study of Parkinson disease in Olmsted County Minnesota. Arch Neurol 60:91-96
7. Louis ED, Bennett DA (2007) Mild Parkinsonian signs: an overview of an emerging concept. Mov Disord 22:1681-1688
8. Forsaa EB, Larsen JP, Wentzel-Larsen T et al (2010) What predicts mortality in Parkinson's disease? A prospective population-based long-term study. Neurology 75:1270-1276
9. Shulman LM, Bhat V (2006) Gender disparities in Parkinson's disease. Expert Rev Neurother 6:407-416
10. Chen H, Zhang SM, Schwarzschild MA, Hernan MA, Ascherio A (2006) Survival of Parkinson's disease patients in a large prospective cohort of male health professionals. Mov Disord 21:1002-1007
11. Guttman M, Slaughter PM, Theriault ME, DeBoer DP (2001) Naylor CD Parkinsonism in Ontario: increased mortality compared with controls in a large cohort study. Neurology 57(12):2278-2282